There is apparently difference between ERK1 and ERK2
MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells. http://www.ncbi.nlm.nih.gov/pubmed/23042098
Forum for people interested in MAP kinases
http://community.mapkinases.eu/